Wieteska-Miłek, M.; Szmit, S.; Florczyk, M.; Kuśmierczyk-Droszcz, B.; Ryczek, R.; Kurzyna, M.
COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination. Vaccines 2021, 9, 1395.
https://doi.org/10.3390/vaccines9121395
AMA Style
Wieteska-Miłek M, Szmit S, Florczyk M, Kuśmierczyk-Droszcz B, Ryczek R, Kurzyna M.
COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination. Vaccines. 2021; 9(12):1395.
https://doi.org/10.3390/vaccines9121395
Chicago/Turabian Style
Wieteska-Miłek, Maria, Sebastian Szmit, Michał Florczyk, Beata Kuśmierczyk-Droszcz, Robert Ryczek, and Marcin Kurzyna.
2021. "COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination" Vaccines 9, no. 12: 1395.
https://doi.org/10.3390/vaccines9121395
APA Style
Wieteska-Miłek, M., Szmit, S., Florczyk, M., Kuśmierczyk-Droszcz, B., Ryczek, R., & Kurzyna, M.
(2021). COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination. Vaccines, 9(12), 1395.
https://doi.org/10.3390/vaccines9121395
